Andy Laperierre, Piper Sandler head of U.S. policy, joins 'Power Lunch' to discuss what will happen regarding the ...

Piper Sandler has upgraded Claritev Corporation (NYSE:CTEV) shares, impressed by the company’s first quarter 2025 results. On ...

Piper Sandler lifted the price target on NVIDIA Corporation (NASDAQ:NVDA) stock from $150 to $180, reaffirming its Overweight ...

Fintel reports that on May 30, 2025, Piper Sandler downgraded their outlook for Zscaler (NasdaqGS:ZS) from Overweight to ...

In a note to clients, Piper Sandler praised the company’s consistent execution and affirmed its bullish stance. Despite the ...

Investing.com -- Piper Sandler analysts said they came away from the 2025 Bitcoin Conference in Las Vegas “incrementally more ...

Piper Sandler lowered its price target on C3.ai, Inc. (NYSE:AI) to $27 from $28 on May 29 while maintaining a Neutral rating ...

In a report released today, Clarke Jeffries from Piper Sandler maintained a Buy rating on Synopsys (SNPS – Research Report), with a price target of $653.00. The company’s shar ...

Detailed price information for Fulcrum Therapeutics Inc (FULC-Q) from The Globe and Mail including charting and trades.

ImmunityBio (NASDAQ: IBRX) gains momentum as Piper Sandler upgrades to Overweight on Anktiva's success and strong growth ...

Methanex ( NASDAQ: MEOH) late Sunday was upgraded to Overweight from a previous investment rating of Neutral by analysts at ...

On Friday, Piper Sandler analyst Jason Bednar spotlighted a selection of Medical Technology (medtech) stocks that are currently considered value investments, emphasizing SOLV and ALGN as the top ...